- Home
- BLCO vs SLGN Comparison
BLCO vs SLGN Comparison
Compare BLCO & SLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- SLGN
- Stock Information
- Founded
- BLCO 1853
- SLGN 1987
- Country
- BLCO Canada
- SLGN United States
- Employees
- BLCO N/A
- SLGN N/A
- Industry
- BLCO Ophthalmic Goods
- SLGN Containers/Packaging
- Sector
- BLCO Health Care
- SLGN Industrials
- Exchange
- BLCO Nasdaq
- SLGN Nasdaq
- Market Cap
- BLCO 4.9B
- SLGN 5.8B
- IPO Year
- BLCO 2022
- SLGN 1997
- Fundamental
- Price
- BLCO $13.72
- SLGN $54.03
- Analyst Decision
- BLCO Hold
- SLGN Strong Buy
- Analyst Count
- BLCO 13
- SLGN 9
- Target Price
- BLCO $15.83
- SLGN $63.89
- AVG Volume (30 Days)
- BLCO 758.1K
- SLGN 610.4K
- Earning Date
- BLCO 07-30-2025
- SLGN 07-30-2025
- Dividend Yield
- BLCO N/A
- SLGN 1.46%
- EPS Growth
- BLCO N/A
- SLGN N/A
- EPS
- BLCO N/A
- SLGN 2.69
- Revenue
- BLCO $4,829,000,000.00
- SLGN $6,004,317,000.00
- Revenue This Year
- BLCO $6.97
- SLGN $12.25
- Revenue Next Year
- BLCO $5.48
- SLGN $2.65
- P/E Ratio
- BLCO N/A
- SLGN $20.41
- Revenue Growth
- BLCO 11.94
- SLGN 1.99
- 52 Week Low
- BLCO $10.45
- SLGN $44.17
- 52 Week High
- BLCO $21.69
- SLGN $58.14
- Technical
- Relative Strength Index (RSI)
- BLCO 63.37
- SLGN 42.82
- Support Level
- BLCO $12.02
- SLGN $54.47
- Resistance Level
- BLCO $14.35
- SLGN $57.01
- Average True Range (ATR)
- BLCO 0.45
- SLGN 0.92
- MACD
- BLCO 0.06
- SLGN -0.17
- Stochastic Oscillator
- BLCO 72.96
- SLGN 5.35
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About SLGN Silgan Holdings Inc.
Silgan Holdings manufactures about half of the metal food containers in North America. Its major customers include Campbell Soup, Nestle, and Del Monte. Silgan's other business segments include plastic dispensers and containers for personal and healthcare products and a closures business that manufactures metal and plastic lids and caps.